Home » NexBio Completes First-in-Man Clinical Trial With DAS181
NexBio Completes First-in-Man Clinical Trial With DAS181
NexBio announces the completion of its First-In-Man clinical trial of DAS181 (Fludase), an investigational drug candidate for influenza.
Yahoo! Finance
Yahoo! Finance
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May